Sign in
Richard S. Danforth

Richard S. Danforth

Chief Executive Officer at Genasys
CEO
Executive
Board

About Richard S. Danforth

Richard S. Danforth, age 65, has served as Chief Executive Officer since August 2016 and as a director since the 2024 annual meeting. He holds a B.S. in Industrial Technology (UMass Lowell) and a Master’s in Engineering Management (Western New England College), with extensive leadership roles across defense and aerospace enterprises . GNSS’s pay-versus-performance disclosure shows compensation actually paid to the PEO of $1.236M in FY2024 alongside company TSR value of $177.11 and a net loss of $31.73M; prior years show TSR values of $72.56 (FY2023) and $38.80 (FY2022) with net losses of $18.40M and $16.21M, respectively . Board leadership is separated (independent Chair), which mitigates dual-role concerns as Danforth is CEO and a director, not Chair .

Past Roles

OrganizationRoleYearsStrategic Impact
RsD Aero, Ltd.Founder (strategic consulting)2014Consulting for Defense/Aerospace/Space/Transportation; emphasis on M&A and transatlantic trade
DRS TechnologiesGroup President, Integrated Defense Systems & Service2013–2014Senior leadership across defense systems
DRS Defense SolutionsCEO, President, Board Member2008–2012Business strategy, leadership, execution at scale
DRS Command Control & CommunicationPresident2005–2008Program leadership in C3 domains
DRS Navy Electronics & Intelligence SystemsPresident2004–2005Operations and product leadership
DRS Electronics Systems GroupEVP2002–2004Senior executive oversight
Raytheon Aircraft CompanyVP Operations; later SVP Commercial Aircraft Business1996–2000Led 370 staff in sales/marketing/customer service; operations leadership
RaytheonManufacturing, QA, Program Mgmt1982–1996Operational and program management foundation

External Roles

OrganizationRoleYearsNotes
Not disclosedNo current outside public company board service disclosed in the proxy

Fixed Compensation

Multi-year summary (fiscal years ended Sept 30):

MetricFY 2023FY 2024
Base Salary$428,685 $437,091
Cash Bonus
All Other Compensation$14,806 $14,454
Total Reported Compensation$667,491 $1,044,150

Notes:

  • Director pay is for non‑employee directors only; Danforth’s compensation is reported as CEO in the executive tables .

Performance Compensation

Annual Incentive Plan (FY2025 framework)

ElementDetail
Target Bonus %75% of base salary (PEO)
Payout Levels50%, 100%, 200% of target, tied to performance goal achievement
Performance MetricsTotal product bookings, net revenues, operating income, operating cash flow (set off FY2024 metrics)
Actual FY2024 Bonus PaidNone reported (— in SCT)
ClawbackNasdaq-compliant policy for restatements; recovery of erroneously received incentive-based compensation; committee discretion for permitted exceptions

Equity Awards Granted (Grant-date fair value)

YearTypeGrant Date Fair Value
FY2023Stock options subject to performance conditions; disclosed aggregate fair value of $1,216,000 (max achievement representation)
FY2024Time-vested stock options; aggregate grant-date fair value $592,605

Outstanding Equity Awards and Vesting

Grant DateTypeExercisableUnexercisablePerf-based UnearnedExercise PriceExpirationVesting Notes
10/4/2019Stock option187,138 $3.39 10/4/2026 Fully vested
10/8/2022Stock option (time-based)100,000 100,000 $2.69 10/8/2029 Vests 1/2 on each anniversary of 10/8/2022
10/8/2022Stock option (performance)400,000 $2.69 10/8/2029 Vests based on performance determined 9/30/2025
10/8/2022Stock option (performance)400,000 $2.69 10/8/2029 Vests based on performance determined 9/30/2026
8/19/2024Stock option (time-based)150,000 300,000 $2.70 8/19/2031 1/3 vests on 9/30/2024, 9/30/2025, 9/30/2026

Pay versus Performance (PEO)

YearPEO Compensation Actually PaidCompany TSR Value ($100 initial)Net Income (Loss)
FY2022$828,008 $38.80 $(16,212,000)
FY2023$553,491 $72.56 $(18,396,000)
FY2024$1,235,962 $177.11 $(31,730,000)

Say‑on‑Pay support at the 2024 annual meeting was 94.3% .

Equity Ownership & Alignment

HolderShares Beneficially Owned% of ClassNear-term Issuable (within 60 days)
Richard S. Danforth731,830 1.6% 537,138 (options/RSUs exercisable/settling within 60 days)
Shares Outstanding (base)44,929,634

Additional alignment considerations:

  • The company has not adopted a hedging policy restricting hedging transactions for directors or employees, which is a misalignment risk indicator for some governance frameworks .
  • No stock ownership guidelines for executives are disclosed; pledging policies are not disclosed .

Employment Terms

ProvisionDetails
RoleEmployment agreement as CEO
Severance (non‑CO)12 months’ salary and health benefits; pro‑rata annual cash bonus for the fiscal year of termination (as if employed through year‑end); vesting of stock options subject to performance-based vesting criteria
Change‑of‑ControlUpon specified termination event in connection with a change of control: lump sum of 2x (base salary + then‑target annual cash bonus), pro‑rata annual bonus, and COBRA coverage cost for 18 months; all stock options vest on termination
Company CIC Plan (general)Separate CIC Severance Benefit Plan provides 24 months’ base salary, target bonus, 24 months’ health benefits, and accelerated vesting for participating executives upon qualifying termination (3 months before/12 months after a CoC)
ClawbackMandatory compensation recovery policy per Nasdaq (restatement-triggered)

Board Governance (Danforth as Director)

  • Board composition: seven directors; six independent; Danforth is CEO and a director; independent Chair is Richard H. Osgood III .
  • Committee memberships: Compensation Committee (Culhane—Chair, Dodd, Osgood); Nominating & Corporate Governance (Osgood—Chair, Schmeiser, Fugate). Danforth is not listed on committees .
  • Attendance: all directors attended at least 75% of Board and applicable committee meetings in FY2024 .
  • Director compensation policy: non‑employee directors receive $30,000 annual cash retainer and annual 30,000 RSUs; no additional committee fees; FY2024 director compensation table disclosed (not applicable to Danforth as employee director) .

Performance & Company Financials

MetricFY 2022FY 2023FY 2024
Revenues (USD)$54,035,000 $46,663,000 $24,008,000
EBITDA (USD)$187,000*$(8,428,000)*$(27,737,000)*
  • Values retrieved from S&P Global.

Risk Indicators & Red Flags

  • Hedging policy: No formal policy restricting hedging for directors or employees; potential alignment concern .
  • Losses and declining revenue in FY2024 vs prior years underscore execution risk .
  • Activist engagement: Cooperation Agreement with Nicoya Capital; Board expanded and new director appointed; indicates shareholder pressure and governance changes .
  • Related party transactions: None exceeding thresholds in FY2024; no current proposals .

Compensation Committee Analysis

  • Composition: Independent directors; Culhane (Chair), Dodd, Osgood .
  • Responsibilities: Set/approve performance goals for executives (including CEO), recommend CEO compensation, administer equity plan, review director compensation; authority to retain advisors .
  • Director compensation cap: Plan limits non‑employee director compensation value to $500,000 per calendar year, with extraordinary exceptions requiring recusal by recipient .

Say‑on‑Pay & Shareholder Feedback

  • Say‑on‑Pay 2024 approval: 94.3% support; company asserts alignment with long‑term stockholder interests .

Investment Implications

  • Alignment: CEO’s target bonus is explicitly tied to bookings, revenue, operating income, and cash flow, with capped payout levels, suggesting clearer pay‑for‑performance mechanics in FY2025; clawback policy adds downside protection for investors .
  • Selling pressure: Multiple option tranches vesting in equal installments through 2026 and two large performance‑based grants maturing on 9/30/2025 and 9/30/2026 create potential supply overhang if exercised; 537,138 shares issuable within 60 days reflects near‑term dilutive potential .
  • Retention/CIC economics: CEO severance (12 months) and double‑trigger CIC (2x salary+target bonus plus full option vesting) are moderate‑to‑robust; could influence incentives around strategic alternatives and reduce departure risk during change‑of‑control scenarios .
  • Governance: Independent Chair and non‑committee status for CEO mitigate dual‑role independence issues; activist cooperation and board refresh are positives for oversight quality .
  • Execution risk: FY2024 revenue contraction and negative EBITDA alongside improved TSR highlight a mismatch between operating results and market performance; FY2025 incentive metrics rooted in cash flow and operating income may pressure near‑term decisions toward profitability and bookings quality .